| Mucormycosis and COVID-19 an epidemic in a pandemic? I Banerjee, J Robinson, M Asim, B Sathian, I Banerjee Nepal journal of epidemiology 11 (2), 1034, 2021 | 30 | 2021 |
| COVID-19 and mutations a threat level assessment J Robinson, I Banerjee, A Leclézio, B Sathian Nepal journal of epidemiology 11 (1), 983, 2021 | 20 | 2021 |
| The art of the editorial ER van Teijlingen, V Hundley, B Sathian, P Simkhada, J Robinson, ... Nepal Journal of Epidemiology 12 (1), 1135, 2022 | 16 | 2022 |
| Corticosteroid induced avascular necrosis and COVID-19: The drug dilemma I Banerjee, J Robinson, B Sathian Nepal journal of epidemiology 11 (3), 1049, 2021 | 16 | 2021 |
| Omicron: The pandemic propagator and lockdown instigator–what can be learnt from South Africa and such discoveries in future I Banerjee, J Robinson, I Banerjee, B Sathian Nepal Journal of Epidemiology 11 (4), 1126, 2021 | 15 | 2021 |
| South Africa and its COVID-19 prohibition predilection I Banerjee, J Robinson, B Sathian, ER van Teijlingen Nepal Journal of Epidemiology 10 (3), 874, 2020 | 14 | 2020 |
| The changing pattern of COVID-19 in Nepal: A Global concern-A Narrative Review I Banerjee, J Robinson, A Kashyap, P Mohabeer, A Shukla, A Leclézio Nepal Journal of Epidemiology 10 (2), 845, 2020 | 12 | 2020 |
| SARS-CoV-2: ACE inhibitors, disastrous or desirable? A Leclézio, J Robinson, I Banerjee Journal of Biomedical Sciences, 40-46, 2020 | 12 | 2020 |
| A contemporary insight of metabolomics approach for COVID-19: Potential for novel therapeutic and diagnostic targets M Asim, B Sathian, I Banerjee, J Robinson Nepal Journal of Epidemiology 10 (4), 923, 2020 | 11 | 2020 |
| COVID-19: Recent advances in epidemiology, virology, etiopathogenesis, clinical trials and vaccine development I Banerjee, P Mohabeer, A Shukla, A Kashyap, J Robinson Journal of Biomedical Sciences, 18-27, 2020 | 11 | 2020 |
| The changing pattern of COVID-19 in Nepal: A Global concern-A Narrative Review. Nepal J Epidemiol. 2020 Jun 30; 10 (2): 845-855 I Banerjee, J Robinson, A Kashyap, P Mohabeer, A Shukla, A Leclézio | 11 | |
| Treatment of long COVID or post COVID syndrome: a pharmacological approach I Banerjee, J Robinson, B Sathian Nepal Journal of Epidemiology 12 (3), 1220, 2022 | 8 | 2022 |
| COVID-19 and Artificial Intelligence: the pandemic pacifier I Banerjee, J Robinson, A Kashyap, P Mohabeer, B Sathian Nepal Journal of Epidemiology 10 (4), 919, 2020 | 8 | 2020 |
| Meaning of success: perception of medical students, and faculty-A qualitative study from a medical school in Mauritius I Banerjee, J Robinson, B Munoosingh, N Jain, RS Amsadevi Nepal Journal of Epidemiology 10 (3), 905, 2020 | 8 | 2020 |
| Rate of depression in Great Britain doubled during COVID-19 pandemic, ONS figures reveal J Robinson Pharm J 1, 1-8, 2020 | 8 | 2020 |
| The Science and practice of pharmacy WYL Thomas, J Robinson, AR Gennaro Easton, Pennsylvania: Mack Publishing Company, 2001 | 8 | 2001 |
| COVID-19: Lockdown and its impact on medical students: A cross sectional study from a medical school in Mauritius I Banerjee, J Robinson, P Mohabeer, A Kashyap, A Shukla, B Sathian Nepal Journal of Epidemiology 11 (2), 1006, 2021 | 7 | 2021 |
| COVID-19: Are reinfections a global health threat? I Banerjee, J Robinson, B Sathian Nepal Journal of Epidemiology 11 (1), 933, 2021 | 6 | 2021 |
| Challenging the stigma J Robinson Pharmaceut J 299, 7907, 2017 | 6 | 2017 |
| Asthma inhaler stocks low after COVID-19 linked demand spike, government says C Wickware, J Robinson Pharm J 10, 2020 | 5 | 2020 |
Dr. Indrajit BanerjeeProfessor,Department of Pharmacology, SSR Medical College, MauritiusVerified email at cmc.edu.np
